PERNIX THERAPEUTICS HLDGS IN - COM (PTX)

CUSIP: 71426V108

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
9,104,504
Share change
-1,000
Total reported value
$22,927,870
Price per share
$2.52
Number of holders
40
Value change
-$3,000
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 71426V108?
CUSIP 71426V108 identifies PTX - PERNIX THERAPEUTICS HLDGS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM (PTX) as of Q4 2013

As of 31 Dec 2013, PERNIX THERAPEUTICS HLDGS IN - COM (PTX) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,104,504 shares. The largest 10 holders included ORBIMED ADVISORS LLC, SAGEVIEW CAPITAL LP, F&C Asset Management plc, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, NORTHERN TRUST CORP, State Street Corp, PUTNAM INVESTMENTS LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 40 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.